Robert Spangenberg

613 total citations
10 papers, 488 citations indexed

About

Robert Spangenberg is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Biomedical Engineering. According to data from OpenAlex, Robert Spangenberg has authored 10 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 2 papers in Surgery and 2 papers in Biomedical Engineering. Recurrent topics in Robert Spangenberg's work include Heart Failure Treatment and Management (5 papers), Cardiac Arrhythmias and Treatments (4 papers) and Cardiac pacing and defibrillation studies (3 papers). Robert Spangenberg is often cited by papers focused on Heart Failure Treatment and Management (5 papers), Cardiac Arrhythmias and Treatments (4 papers) and Cardiac pacing and defibrillation studies (3 papers). Robert Spangenberg collaborates with scholars based in United States, Germany and Sweden. Robert Spangenberg's co-authors include Lester F. Soyka, Barry F. Uretsky, P S Reddy, William P. Follansbee, William W. Parmley, Kanu Chatterjee, Dean J. Kereiakes, Richard Kehoe, Terry Zheutlin and Thomas A. Mattioni and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Robert Spangenberg

10 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Spangenberg United States 8 454 77 49 41 32 10 488
R. Coxon New Zealand 6 324 0.7× 62 0.8× 37 0.8× 59 1.4× 54 1.7× 7 422
T H Pringle United Kingdom 10 254 0.6× 40 0.5× 40 0.8× 27 0.7× 31 1.0× 16 359
Christian van Eyll Belgium 15 605 1.3× 85 1.1× 94 1.9× 46 1.1× 47 1.5× 49 676
Kathleen E. Needham United States 9 256 0.6× 41 0.5× 79 1.6× 61 1.5× 32 1.0× 17 320
Marvin F. Blanford United States 5 180 0.4× 71 0.9× 76 1.6× 24 0.6× 22 0.7× 7 331
Robert J. Hoeschen Canada 10 207 0.5× 87 1.1× 28 0.6× 21 0.5× 31 1.0× 23 303
Isao K. Inouye United States 8 603 1.3× 20 0.3× 41 0.8× 66 1.6× 33 1.0× 9 666
Angas Hamer Australia 16 903 2.0× 79 1.0× 107 2.2× 10 0.2× 29 0.9× 40 986
D S Thompson United Kingdom 12 430 0.9× 46 0.6× 103 2.1× 18 0.4× 30 0.9× 17 525
Rodolphe Ruffy United States 17 585 1.3× 83 1.1× 69 1.4× 8 0.2× 24 0.8× 43 719

Countries citing papers authored by Robert Spangenberg

Since Specialization
Citations

This map shows the geographic impact of Robert Spangenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Spangenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Spangenberg more than expected).

Fields of papers citing papers by Robert Spangenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Spangenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Spangenberg. The network helps show where Robert Spangenberg may publish in the future.

Co-authorship network of co-authors of Robert Spangenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Spangenberg. A scholar is included among the top collaborators of Robert Spangenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Spangenberg. Robert Spangenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Spangenberg, Robert & Ralf Reulke. (2008). Objektverfolgung mit Partikel-Filtern. elib (German Aerospace Center). 1 indexed citations
2.
Kehoe, Richard, Daniel J. MacNeil, Terry Zheutlin, et al.. (1993). Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents. The American Journal of Cardiology. 72(4). A56–A66. 38 indexed citations
3.
Soyka, Lester F., et al.. (1990). Clinical safety profile of sotalol in patients with arrhythmias. The American Journal of Cardiology. 65(2). 74–81. 121 indexed citations
4.
Kehoe, Richard, et al.. (1990). Safety and efficacy of sotalol in patients with drug-refractory sustained ventricular tachyarrhythmias. The American Journal of Cardiology. 65(2). 58–64. 51 indexed citations
5.
Amin, Devendra K., Prediman K. Shah, Frank G. Shellock, et al.. (1985). Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure. American Heart Journal. 109(1). 91–98. 28 indexed citations
6.
Kereiakes, Dean J., et al.. (1984). Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients. Journal of the American College of Cardiology. 4(5). 884–889. 70 indexed citations
7.
Kereiakes, Dean J., Christian E. Viquerat, Peter Lanzer, et al.. (1984). Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure. American Heart Journal. 108(5). 1278–1284. 32 indexed citations
8.
Uretsky, Barry F., et al.. (1984). Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure. The American Journal of Cardiology. 54(3). 357–362. 31 indexed citations
9.
Uretsky, Barry F., et al.. (1983). The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.. Circulation. 67(4). 823–828. 114 indexed citations
10.
Stowe, Nicholas T., et al.. (1970). Effect of glucagon in hemorrhagic shock. Journal of Surgical Oncology. 2(2). 177–187. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Coxon Breakdown of academic impact, for papers by T H Pringle Breakdown of academic impact, for papers by Christian van Eyll Breakdown of academic impact, for papers by Kathleen E. Needham Breakdown of academic impact, for papers by Marvin F. Blanford Breakdown of academic impact, for papers by Robert J. Hoeschen Breakdown of academic impact, for papers by Isao K. Inouye Breakdown of academic impact, for papers by Angas Hamer Breakdown of academic impact, for papers by D S Thompson Breakdown of academic impact, for papers by Rodolphe Ruffy
Rankless by CCL
2026